• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 3. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylazides

Chemical Profile of 4-Azido-1-bromo-2-iodobenzene (CAS No. 1694788-75-4)

4-Azido-1-bromo-2-iodobenzene, identified by its Chemical Abstracts Service (CAS) number 1694788-75-4, is a specialized organic compound that has garnered significant attention in the field of synthetic chemistry and pharmaceutical research. This heterocyclic aromatic molecule features a unique structural arrangement of bromine and iodine substituents alongside an azido functional group, making it a versatile intermediate in the synthesis of more complex molecules.

The structural motif of 4-Azido-1-bromo-2-iodobenzene consists of a benzene ring substituted at the 1-position with a bromine atom, at the 2-position with an iodine atom, and at the 4-position with an azido group (–N?). This particular configuration imparts distinct reactivity patterns that are exploited in various chemical transformations. The presence of both bromine and iodine atoms allows for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura, Stille, or Sonogashira couplings, which are pivotal in constructing biaryl structures commonly found in biologically active compounds.

In recent years, the demand for novel building blocks like 4-Azido-1-bromo-2-iodobenzene has surged due to their utility in drug discovery and material science. The azido group, in particular, is a valuable handle for introducing nitrogen-containing heterocycles or for generating strained alkenes through azide-to-alkyne cycloadditions (azide-alkyne cycloaddition, or AzAD). This reaction is widely employed in medicinal chemistry to construct complex cyclic frameworks efficiently.

One of the most compelling applications of 4-Azido-1-bromo-2-iodobenzene lies in its role as a precursor for developing small-molecule inhibitors targeting various biological pathways. For instance, researchers have leveraged its reactivity to synthesize derivatives that interact with enzymes involved in cancer metabolism. The benzene core itself is a scaffold frequently encountered in pharmacophores, and modifications at the 1-, 2-, and 4-positions allow for fine-tuning of electronic and steric properties to optimize binding affinity.

Recent advances in flow chemistry have also highlighted the utility of 4-Azido-1-bromo-2-iodobenzene as a starting material for scalable syntheses. Flow-based approaches enable higher yields and better reproducibility compared to traditional batch methods, making this compound particularly attractive for industrial applications. Moreover, the ability to perform sequential reactions within a continuous flow system minimizes side reactions and improves purification efficiency.

The synthesis of 4-Azido-1-bromo-2-iodobenzene typically involves multi-step organic transformations starting from commercially available aromatic precursors. Key steps often include halogenation strategies to introduce bromine and iodine at specific positions, followed by selective nitration or azidation to install the azido group. Optimizing reaction conditions—such as temperature, solvent choice, and catalyst systems—is crucial to achieving high regioselectivity and yield.

The mechanistic understanding of reactions involving 4-Azido-1-bromo-2-iodobenzene has been further refined through computational studies. Molecular modeling techniques have provided insights into how steric and electronic factors influence reaction outcomes, enabling chemists to predict outcomes more accurately and design novel synthetic routes with greater confidence. These computational tools are particularly valuable when dealing with complex transformations where experimental optimization alone may be inefficient.

In pharmaceutical development, 4-Azido-1-bromo-2-iodobenzene derivatives have been explored as tools for fragment-based drug design. By systematically modifying substituents on the benzene ring, researchers can identify lead compounds that exhibit desired biological activity. The combination of bromine and iodine handles provides multiple opportunities for further derivatization via transition-metal-catalyzed reactions, allowing for rapid diversification of molecular structures.

The role of 4-Azido-1-bromo-2-iodobenzene extends beyond pharmaceuticals into materials science. For example, its derivatives have been used to functionalize polymers with nitrogen-rich groups, enhancing properties such as thermal stability or biodegradability. The ability to introduce both bromine and iodine atoms into aromatic systems also makes this compound useful for studying halogen bonding interactions—a phenomenon with potential applications in supramolecular chemistry.

As interest in green chemistry grows, efforts have been made to develop sustainable synthetic routes for 4-Azido-1-bromo-2-iodobenzene. Catalytic methods that minimize waste and reduce energy consumption are being prioritized. Additionally, solvent-free or aqueous-phase reactions are being investigated to align with environmental regulations while maintaining high chemical yields.

The future prospects for 4-Azido-1-bromo-2-iodobenzene remain promising as new methodologies emerge in synthetic organic chemistry. Advances in photoredox catalysis, electrochemical synthesis, and biocatalysis may open up additional avenues for its utilization. Furthermore, interdisciplinary collaborations between chemists and biologists will continue to drive innovation by applying this versatile intermediate to solve complex biological problems.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)